Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
91.79
USD
|
+0.69%
|
|
+1.54%
|
-3.44%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,384
|
9,624
|
5,278
|
2,714
|
3,102
|
2,999
|
-
|
-
|
Enterprise Value (EV)
1 |
5,596
|
9,758
|
5,680
|
3,095
|
3,361
|
3,304
|
3,310
|
2,999
|
P/E ratio
|
43.5
x
|
53.1
x
|
25.5
x
|
23
x
|
-317
x
|
25.9
x
|
19.7
x
|
20.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.75
x
|
4.65
x
|
2.38
x
|
1.22
x
|
1.39
x
|
1.29
x
|
1.2
x
|
1.14
x
|
EV / Revenue
|
2.86
x
|
4.71
x
|
2.57
x
|
1.39
x
|
1.5
x
|
1.42
x
|
1.33
x
|
1.14
x
|
EV / EBITDA
|
24.8
x
|
35.7
x
|
19
x
|
11.8
x
|
13.6
x
|
13.1
x
|
12.1
x
|
-
|
EV / FCF
|
28.8
x
|
35
x
|
31.1
x
|
24.3
x
|
25.5
x
|
20.8
x
|
18.4
x
|
-
|
FCF Yield
|
3.47%
|
2.86%
|
3.21%
|
4.11%
|
3.91%
|
4.82%
|
5.43%
|
-
|
Price to Book
|
8.41
x
|
11.9
x
|
5.65
x
|
2.58
x
|
2.91
x
|
2.32
x
|
2.05
x
|
-
|
Nbr of stocks (in thousands)
|
32,255
|
32,811
|
32,602
|
32,492
|
32,633
|
32,677
|
-
|
-
|
Reference price
2 |
166.9
|
293.3
|
161.9
|
83.54
|
95.06
|
91.79
|
91.79
|
91.79
|
Announcement Date
|
2/18/20
|
2/24/21
|
2/23/22
|
2/15/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,956
|
2,072
|
2,214
|
2,223
|
2,236
|
2,328
|
2,495
|
2,626
|
EBITDA
1 |
225.3
|
273.5
|
299.6
|
262.1
|
247
|
252.2
|
272.9
|
-
|
EBIT
1 |
206.9
|
244.7
|
268.7
|
237.1
|
223.2
|
228.1
|
248.4
|
-
|
Operating Margin
|
10.58%
|
11.81%
|
12.14%
|
10.67%
|
9.98%
|
9.8%
|
9.96%
|
-
|
Earnings before Tax (EBT)
1 |
170.4
|
210.8
|
280.2
|
160.2
|
39.62
|
168.6
|
215.5
|
-
|
Net income
1 |
126.8
|
183.6
|
209.1
|
118.6
|
-9.747
|
117.7
|
155.7
|
159.3
|
Net margin
|
6.49%
|
8.86%
|
9.44%
|
5.34%
|
-0.44%
|
5.06%
|
6.24%
|
6.07%
|
EPS
2 |
3.840
|
5.520
|
6.340
|
3.630
|
-0.3000
|
3.545
|
4.670
|
4.530
|
Free Cash Flow
1 |
194.1
|
279.2
|
182.6
|
127.1
|
131.6
|
159.2
|
179.9
|
-
|
FCF margin
|
9.93%
|
13.48%
|
8.25%
|
5.72%
|
5.88%
|
6.84%
|
7.21%
|
-
|
FCF Conversion (EBITDA)
|
86.16%
|
102.06%
|
60.95%
|
48.51%
|
53.26%
|
63.11%
|
65.92%
|
-
|
FCF Conversion (Net income)
|
153.05%
|
152.05%
|
87.33%
|
107.17%
|
-
|
135.21%
|
115.57%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/18/20
|
2/24/21
|
2/23/22
|
2/15/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
559.3
|
545.3
|
557.9
|
558
|
562.1
|
556.4
|
553
|
556.2
|
570.8
|
571.4
|
575.1
|
582.9
|
596.5
|
614.4
|
628.1
|
EBITDA
1 |
64.81
|
66.31
|
74.35
|
61.51
|
59.89
|
57.84
|
74.64
|
57.88
|
56.65
|
59.86
|
63.47
|
63.82
|
66.49
|
62.06
|
70.72
|
EBIT
1 |
55.67
|
58.3
|
68.13
|
56.03
|
54.66
|
52.14
|
68.44
|
51.82
|
50.76
|
53.72
|
57.5
|
58.62
|
58.2
|
54.24
|
64.44
|
Operating Margin
|
9.95%
|
10.69%
|
12.21%
|
10.04%
|
9.72%
|
9.37%
|
12.38%
|
9.32%
|
8.89%
|
9.4%
|
10%
|
10.06%
|
9.76%
|
8.83%
|
10.26%
|
Earnings before Tax (EBT)
1 |
46.88
|
43.73
|
40.36
|
34.82
|
41.34
|
34.71
|
-62.23
|
37.95
|
29.2
|
27.23
|
39.98
|
42.49
|
42.87
|
48.46
|
56.15
|
Net income
1 |
34.05
|
31.67
|
29.58
|
25.64
|
31.72
|
25.25
|
-80.28
|
25.96
|
19.32
|
14.4
|
34.74
|
35.73
|
36.58
|
35.44
|
41.25
|
Net margin
|
6.09%
|
5.81%
|
5.3%
|
4.6%
|
5.64%
|
4.54%
|
-14.52%
|
4.67%
|
3.39%
|
2.52%
|
6.04%
|
6.13%
|
6.13%
|
5.77%
|
6.57%
|
EPS
2 |
1.040
|
0.9700
|
0.9100
|
0.7900
|
0.9700
|
0.7700
|
-2.460
|
0.7900
|
0.5900
|
0.4400
|
1.010
|
1.045
|
1.050
|
1.062
|
1.238
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/23/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/15/23
|
5/3/23
|
7/26/23
|
10/24/23
|
2/21/24
|
4/24/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
212
|
133
|
402
|
381
|
259
|
305
|
311
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.9405
x
|
0.487
x
|
1.343
x
|
1.453
x
|
1.05
x
|
1.208
x
|
1.139
x
|
-
|
Free Cash Flow
1 |
194
|
279
|
183
|
127
|
132
|
159
|
180
|
-
|
ROE (net income / shareholders' equity)
|
25.9%
|
28.1%
|
22.5%
|
16.5%
|
13.3%
|
13%
|
13.3%
|
-
|
ROA (Net income/ Total Assets)
|
14.7%
|
14.4%
|
11.5%
|
8.53%
|
6.97%
|
7.13%
|
8.12%
|
-
|
Assets
1 |
864.5
|
1,278
|
1,825
|
1,391
|
-139.9
|
1,650
|
1,918
|
-
|
Book Value Per Share
2 |
19.80
|
24.70
|
28.60
|
32.30
|
32.60
|
39.60
|
44.70
|
-
|
Cash Flow per Share
2 |
6.120
|
8.690
|
5.730
|
4.080
|
4.210
|
5.070
|
6.960
|
-
|
Capex
1 |
7.89
|
5.33
|
6.3
|
6.17
|
5.62
|
7.51
|
7.3
|
-
|
Capex / Sales
|
0.4%
|
0.26%
|
0.28%
|
0.28%
|
0.25%
|
0.32%
|
0.29%
|
-
|
Announcement Date
|
2/18/20
|
2/24/21
|
2/23/22
|
2/15/23
|
2/21/24
|
-
|
-
|
-
|
Last Close Price
91.79
USD Average target price
97.78
USD Spread / Average Target +6.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.44% | 3B | | 0.00% | 1.81B | | +1.82% | 1.53B | | +49.28% | 624M | | -3.09% | 503M | | -35.42% | 368M | | -13.04% | 136M | | +1.92% | 67.7M |
Home Healthcare Services
|